Loading…
Lobbying Income
$330K
Filings
34
Unique Clients
1
Active Period
2017–2025
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377) and/or other permanent reforms of Sec. 216 of the Protecting Access to Medicare Act of 2014 (PAMA); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of PAMA.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2377
Medical Laboratory Personnel Shortage Relief Act of 2024
2024 · fourth_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to the Medical Laboratory Personnel Shortage Relief Act of 2024 (H.R.9849); support robust funding for the Centers for Disease Control Prevention's Advanced Molecular Detection program.
Client expense: — · Firm income: $10,000
Matched citations: H.R.9849
Chesapeake Bay Accountability and Recovery Act of 2014
2024 · fourth_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377) and/or other permanent reforms of Sec. 216 of the Protecting Access to Medicare Act of 2014 (PAMA); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of PAMA.
Client expense: — · Firm income: $10,000
Matched citations: S. 1000
Freedom To Invest in Tomorrow's Workforce Act
2024 · third_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Legislation to regulate laboratory-developed in vitro diagnostic (IVD) tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to the Medical Laboratory Personnel Shortage Relief Act of 2024 (H.R.9849); support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1477
VALID Act of 2023
2024 · third_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Legislation to regulate laboratory-developed in vitro diagnostic (IVD) tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to the Medical Laboratory Personnel Shortage Relief Act of 2024 (H.R.9849); support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2369
Saving Access to Laboratory Services Act
2024 · third_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2377
Improving Seniors’ Timely Access to Care Act of 2024
2024 · third_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 8702
Medical Laboratory Personnel Shortage Relief Act of 2024
2024 · third_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Legislation to regulate laboratory-developed in vitro diagnostic (IVD) tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to the Medical Laboratory Personnel Shortage Relief Act of 2024 (H.R.9849); support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R.9849
Saving Access to Laboratory Services Act
2024 · third_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Client expense: — · Firm income: $10,000
Matched citations: S. 1000
Improving Seniors’ Timely Access to Care Act of 2024
2024 · third_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Client expense: — · Firm income: $10,000
Matched citations: S. 4532
Freedom To Invest in Tomorrow's Workforce Act
2024 · third_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Legislation to regulate laboratory-developed in vitro diagnostic (IVD) tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to the Medical Laboratory Personnel Shortage Relief Act of 2024 (H.R.9849); support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: S. 722
Freedom To Invest in Tomorrow's Workforce Act
2024 · second_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1477
VALID Act of 2023
2024 · second_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2369
Saving Access to Laboratory Services Act
2024 · second_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2377
Improving Seniors’ Timely Access to Care Act of 2024
2024 · second_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 8702
Saving Access to Laboratory Services Act
2024 · second_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Client expense: — · Firm income: $10,000
Matched citations: S. 1000
Improving Seniors’ Timely Access to Care Act of 2024
2024 · second_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Client expense: — · Firm income: $10,000
Matched citations: S. 4532
Freedom To Invest in Tomorrow's Workforce Act
2024 · second_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: S. 722
Freedom To Invest in Tomorrow's Workforce Act
2024 · first_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1477
VALID Act of 2023
2024 · first_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2369
Saving Access to Laboratory Services Act
2024 · first_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2377
Saving Access to Laboratory Services Act
2024 · first_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014.
Client expense: — · Firm income: $10,000
Matched citations: S. 1000
Freedom To Invest in Tomorrow's Workforce Act
2024 · first_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: S. 722
Freedom To Invest in Tomorrow's Workforce Act
2023 · fourth_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory; monitor legislation to regulate laboratory-developed in vitro diagnostic tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1477
VALID Act of 2023
2023 · fourth_quarter · Client: AMERICAN MEDICAL TECHNOLOGISTS
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory; monitor legislation to regulate laboratory-developed in vitro diagnostic tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2369
Source: Senate LDA